Table 3.
Relationship between TyG index and progression-free survival.
| TyG index | Non-adjusted | P-value | Adjust I | P-value | Adjust II | P-value |
|---|---|---|---|---|---|---|
| Continuous | 1.873 (1.235 - 2.840) | 0.003 | 2.090 (1.286 - 3.396) | 0.003 | 1.905 (1.017 - 3.570) | 0.044 |
| Group | ||||||
| Low | 1.000 (Reference) | 1.000 (Reference) | 1.000 (Reference) | |||
| High | 3.430 (1.908 - 6.167) | <0.001 | 4.085 (2.195 - 7.601) | <0.001 | 5.405 (2.383 - 12.261) | <0.001 |
Non-adjusted model adjusted for: None. Adjust I model adjusted for: Gender, Age and BMI. Adjust II model adjusted for: Repeat TURBT, Gender, Hypertension, Diabetes, Smoking, Prior recurrence status, Tumor number, Pathology grade, T category, IVI times, Maximum tumor diameter, TC, HDL-C, Hb, Alb, Platelet count, Neutrophil count, Lymphocyte count, Age and BMI.